November 8, 2019 Announcements

November 8, 2019

Announcements

Care Center Opens in Westerly

Dr. Anne Chiang, Maura Legare, Dr. Robert Legare, Dr. Rebecca News Center Vanasse-Passas I was pleased to join the leadership of Yale New Haven Health,

Westerly Hospital, and Smilow Cancer Hospital as we celebrated the opening of our 15th Care Center at Westerly last week. Drs. Robert Legare and Rebecca Vanasse-Passas are now seeing their patients in our newly renovated space at Westerly Hospital and we look forward to collaborating with them on the care of their patients. Thank you to both of them, Mary Ann Nash, Dr. Anne Chiang, Art Lemay, and many others who have dedicated their efforts to a seamless transition for the patients in the Westerly area. Smilow Cancer Hospital expert explains five things Palliative Care Conference you need to know Please join our Palliative Care Program for a special CME program about Lung Cancer on Wednesday, November 13 at Yale West Campus at 4pm. Read More >> Titled, Why Be Afraid, the program will use theatrical devices to tell the story of how palliative medicine is supportive of curative care in the medical setting. Learn More >>

Hematological Malignancies Symposium

Smilow Cancer Hospital at Saint Francis and Yale Cancer Center Dr. Susan Rabnowe invite you to join colleagues and experts in hematological talks about metastatic malignancies from around the nation on Friday, November 15 at the breast cancer on Connecticut Convention Center. The program is free, but FOX61 registration is required. Read More >> Learn More >> Fellows Research Competition >>

Imaging Mass Spectrometry and Omics Symposium Yale School of Public Health will host a one day Imaging Mass Spectrometry and Omics Symposium on Friday, November 22 in the Winslow Auditorium with colleagues presenting from Yale and Westerly Hospital around the country. opens new Smilow Care Center Learn More >> Read More >> Register >>

Notables

The Society for Immunotherapy of Cancer (SITC) annual meeting begins this weekend and will feature several presentations from Yale Cancer Center and Smilow Cancer Hospital faculty. Mario Sznol, MD, is president of SITC this year and Marianne Davies, DNP, AOCNP, is on the annual meeting committee. For a full list of Smilow Cancer presentations from Yale, please check our website. Hospital celebrates 10th anniversary

Read More >> Nita Ahuja, MD, current Chief of Surgery at Yale New Haven Hospital and Chair of Surgery at Yale School of Medicine, has been appointed as Surgeon-in-Chief of Yale New Haven Hospital. Dr. Ahuja's responsibilities in this role include serving as executive co- sponsor of the Yale New Haven Health System's Surgical Services Executive Committee (SSEC) and as Chair of the YNHH Surgical Join Smilow Services Governance Committee (SSGC). Cancer Hospital on Facebook Congratulations to our Hematology team, Steven Gore, MD, Principal Investigator, and our Clinical Trials Office. Our participation in ECOG's A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults led to Yale having the third Latest Posts: highest accrual site, an accomplishment that was celebrated at the recent ECOG meeting. Happy birthday to Marie Curie from Smilow Radiation Daniel Boffa, MD, Professor of Surgery (Thoracic Surgery), has Oncology! Marie Curie been appointed Chair of the Commission on Cancer (CoC) was the first woman to Quality Integration Committee and to the CoC Executive win the Nobel Prize. Her research in the late Committee. 1800s led to the development of the life- saving radiotherapy Congratulations to Marianne Davies and Vanna Dest, who were that is currently used to honored during Advanced Practice Provider week with honors by treat cancer patients. Yale New Haven Health. Marianne was awarded the 2019 APP Publishing Award, which highlights clinically practicing APP who has made significant advancements by publishing or implementing their research efforts or quality initiatives to the gain of YNHH patients or staff. Vanna was honored with the 2019 Gratitude Award in recognition of her leadership of the APP Week Planning Committee as well as her contributions to the APP field and support of her colleagues. Read More >>

Jill Lacy, MD, Professor of Medicine (Medical Oncology), has been The Yale University appointed to the Dean's Faculty Advisory Council to represent Police Yale Cancer Center. Department wore pink patches the entire month of October to Roy S. Herbst, MD, PhD, will give the Waun Ki Hong Memorial raise awareness and Lecture at the AACR-Korean Cancer Association Joint Workshop funds for breast cancer on Precision Medicine next week on "Personalized Therapy for awareness. Additionally, their Advanced Non-Small Cell Lung Cancer: From BATTLE to Runners Club created Immunotherapy." Running Club Pink shirts for the month and all proceeds were The Thoracic Oncology Program co-hosted a Lung Cancer added to the Pink Retreat with Mount Sinai last week at Greenwich Hospital to focus Patch Fundraiser. Thank you to the entire on opportunities in collaborative research. Co-chaired by Sarah department for your Goldberg, MD, and Fred Hirsch, MD, the program featured support of the Breast presentations from both institutions and an opportunity to network Center at Smilow and brainstorm future research projects. Cancer Hospital! Read More >>

Congratulations to the following faculty in Medical Oncology and William was out of Hematology who were promoted this year: Scott Gettinger, MD, options to treat his lymphoma until Dr. Iris Professor; Sarah Goldberg, MD, MPH, Associate Professor; Lucia Isufi was able to offer Jilaveanu, MD, PhD, Associate Professor; Joseph Kim, MD, cutting edge CAR T- Associate Professor; Nikolai Podoltsev, MD, PhD, Associate cell therapy to him Professor; Tara Sanft, MD, Associate Professor; Stacey Stein, MD, Smilow Cancer Associate Professor; and Amer Zeidan, MBBS, Associate Hospital earlier this year. He is now getting Professor. stronger every day.

Dr. Nita Ahuja has announced the following promotions of Smilow Cancer Hospital/ Yale Cancer Center members in the Department of Surgery: Justin Blasberg, MD, MPH, Associate Professor of Thoracic Surgery; Daniel Boffa, MD, Professor of Thoracic Surgery; Anees Chagpar, MD, MBA, MPH, Professor of Oncology; Sajid Watch the story >> Khan, MD, Associate Professor of Oncology; Saral Mehra, MD, MBA, Associate Professor of Otolaryngology. The volleyball teams Dr. Peter Glazer announced the following appointments and from Daniel Hand High School in Madison, CT promotions in Therapeutic Radiology: Joseph Contessa, MD, PhD, hosted a Dig Pink Professor of Therapeutic Radiology in the Traditional Track; James Game against Guilford Yu, MD, MHS, Professor of Therapeutic Radiology in the Clinician High School to support Educator Track; Brian Wang, PhD, Professor of Therapeutic our Breast Center at Radiology in the Clinician Educator Track, and Kimberly Johung, Smilow Cancer Hospital. Thank you for MD, PhD, Associate Professor of Therapeutic Radiology in the creating a sea of pink Clinician Educator Track. at the game and for your amazing support of our patients!

Read More >> Cancer Immunology is proud to welcome Jeanne Hendrickson, MD, Professor of Laboratory Medicine Looking for an easy to and Pediatrics. Dr. Jeanne eat, protein rich meal? Hendrickson is a pediatric Check out this hematologist/oncologist and the seasonal soup Medical and Facility Director of the recommended by our nutritionists! Filled with Smilow Apheresis Clinic. Her primary 13 grams of protein clinical and research interests are and rich in vegetables focused on transfusion medicine and and healthy grains, this alloimmunization as a complication of soup will fill your body with valuable nutrients. PRBC transfusion. The research Further, it's soft and aspects are relevant for supportive easy to eat. care of patients requiring multiple PRBC transfusions. Because of her Check out this Hearty role in leading and coordinating the Turkey Minestrone Soup and many other apheresis and cell collections, Dr. recipes on our recipe Hendrickson will be a key participant page. in all cell therapy protocols for Yale Cancer Center.

Research Highlights

In honor of our 10th Anniversary, a few of our physicians and staff share why they are so passionate about being a part of our Smilow Cancer Hospital and Yale Cancer Center team helping to fight cancer!

The checkpoint inhibitor pembrolizumab offers patients with advanced head and neck cancers longer survival time, according to a new global study led by Yale Cancer Center. The data was published in the journal The Lancet. Watch the Story >>

The findings show overall survival was significantly improved through a phase 3 study for participants with previously untreated Happy Halloween from just a few of our many recurrent or metastatic head and neck cancers, compared to the caring heroes who standard therapy. "This research demonstrates that use of this dressed the part today checkpoint inhibitor, with or without chemotherapy, should be the to share in the fun with first drug used for these types of cancers," said the study's lead our littlest patients! investigator, Barbara Burtness, MD. "This is a very positive advance in treatment for our patients." Learn More >>

A survey of U.S. hematology-oncology fellows suggests Read More >> medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly Representatives from when students are exposed to the Smilow Breast hematology and oncology as part of Center traveled to West core clerkships in internal medicine and Haven to meet with Mayor Nancy Rossi pediatrics. The study, funded by the along with Tony American Society of Hematology (ASH) Cordone and Beth and published last week in Blood Sabo from the West Advances, also indicates that having a Haven Breast Cancer Awareness Program. hematologist as a mentor during medical education and training is Tony and Beth associated with an increased likelihood of fellows specializing in presented a check for hematology when they complete their hematology-oncology $34,000, the proceeds fellowship. from the 19th annual Icy Plunge in January.

"These findings give us a better understanding of why trainees The Program has supported breast pursue hematology and suggests ways we can be proactive to cancer patients since ensure the supply of hematologists keeps up with demand, 2003 and has been particularly in non-malignant blood diseases, such as sickle cell responsible for disease, hemophilia, and other bleeding and clotting disorders," said approximately $500,000 in donations. Alfred Lee, MD, PhD. We are so grateful to Learn More >> Beth and her colleagues for their extraordinary Employee Profile: Naralys Sinanis generosity and spirit that has accompanied each gift through the years to help and comfort and support our breast cancer patients.

In 2016, Smilow Cancer Read More >> Hospital/Yale Medicine were selected by the Centers for Medicare and Medicaid Services #OOTBThanks (CMS) to participate in the Oncology to our NP-4 Care Model (OCM) program. OCM Medical supports and encourages higher Assistants! quality, more coordinated cancer care with lower costs. As the OCM Program Manager, Naralys "Nara" Sinanis oversees Smilow's participation in this model as well as all of the care model's requirements, ensuring Smilow stays within the guidelines set by the CMS.

YCC Nara works closely with Smilow's #OUTOFTHEBLUET OCM Executive team, helping to set HANKS recently goals to support our participation in the care model. Such goals can recognized the include reducing hospitalizations and visits to the emergency following Medical department. Day to day, Nara also works with tumor registry staff, Assistants from NP- data analysts, and care coordinators across our Network to track 4: Iris Munoz, clinical and quality measures and to assess opportunities for Alvaro Cabrera, Delisa Claxton, improvement. Nara is responsible for reporting performance data to Qiydaar Kirk, Coral CMS and staying up to date on changes to the model's Yesenia Reyes, and requirements. Crystal Comstock.

"As the manager of this complex program, Naralys has taken This team was ownership of every aspect of implementation and execution--from commended after understanding complex patient eligibility criteria, developing novel their response to a billing workflows, overseeing quality reporting, and most importantly recent code that supervising implementation of new clinical programs," said Kerin occurred in the Adelson, MD, Chief Quality Officer and Associate Chief Medical reception area of our NP-4 Multispecialty Officer for Smilow Cancer Hospital. "She built workgroups with Clinic. While keeping stakeholders from across the YNHH and Yale Medicine. Using a calm demeanor, revenue from OCM to fund clinical infrastructure, Naralys has the team was overseen the opening of our Oncology Extended Care Center - effective and open 16 hours a day, 7 days a week - the development of a care professional in management program and launch of Via Oncology clinical decision managing the code. support which required a complex EPIC integration." Thank you, your continuous dedication to our "Our success in this program is clear through steady improvements patients is very much in hospital admission rates, ED visits, and reductions in use of post- appreciated! acute care," continued Dr. Adelson. "Our primary motivation in electing to participate in this program was to improve patient care Yale Cancer and learn about how to succeed in a value-based environment. Our Center's financial success in the program is an added bonus. We have #OOTBTHANKS earned maximal quality points in all performance periods so far and this has led to significant performance-based payments. None of program is a staff this would have been possible without Naralys' dedication and recognition initiative commitment to care transformation." to show appreciation to employees who have exemplified an "Our OCM team genuinely cares about quality improvement and above-and-beyond making a difference for our patients and families," said Nara. "It's effort or an energizing to receive positive feedback from patients and providers outstanding about our care coordinators and our extended care clinic. To me, contribution to the that feedback is the most compelling data we have to show that this team. All program is truly enhancing care." nominations should be submitted to the Recent Publications Director's Office c/o Anna Raso.

Immunotherapy for head and neck cancer: Recent advances and future directions. Cramer JD, Burtness B, Ferris RL. Follow Yale Oral Oncol. 2019 Nov 1;99:104460. Cancer Read More >> Center on Twitter Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Watch Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, .@CharlesFuchsMD Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González discuss recent updates Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; from @SmilowCancer and @YaleCancer and KEYNOTE-048 Investigators. the amazing work we Lancet. 2019 Oct 31. have planned for our future of #cancer care Read More >> and research

Strengths and limitations of large databases in lung cancer radiation oncology research. A new survey .@BloodAdvances led Jairam V, Park HS. by Dr. Alfred Lee Transl Lung Cancer Res. 2019 Sep;8(Suppl 2):S172-S183. shows medical students that have a Read More >> #hematologist as a mentor helps steer Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas. them into a Patel N, Barbieri A, Gibson J. #hematology career. Surg Pathol Clin. 2019 Dec;12(4):1021-1044. Read More >> Thank you to our Grand Rounds Serum gamma-glutamyltransferase and the overall survival of speakers today: Dr. Andrew Xiao talking metastatic pancreatic cancer. about #Epigenetics and Xiao Y, Yang H, Lu J, Li D, Xu C, Risch HA. #cancer and Dr. Donna Spiegelman focusing BMC Cancer. 2019 Oct 29;19(1):1020. on implementation Read More >> science in cancer.

Characterization of NCS1-InsP3R1 interaction and its functional significance. "There is a desperate need for new Nguyen LD, Petri ET, Huynh LK, Ehrlich BE. therapies to improve J Biol Chem. 2019 Oct 28. pii: jbc.RA119.009736 the care of patients with advanced Read More >> #pancreaticcancer" - Dr. Mandar Muzumdar. Transmissible inflammation-induced colorectal cancer in Read how the inflammasome-deficient mice. @MuzumdarLab is leading research to Hu B, Friedman G, Elinav E, Flavell RA. treat the disease. Oncoimmunology. 2018 May 7;8(10):e981995. Read More >> Plan to join us for our 4th annual Increased expression of TET3 predicts unfavorable prognosis in Hematologic patients with ovarian cancer-a bioinformatics integrative analysis. Malignancies Cao T, Pan W, Sun X, Shen H. Symposium on Friday November 15 at the J Ovarian Res. 2019 Oct 27;12(1):101. @ctconventionctr with Read More >> @SaintFrancisCT@Sm ilowCancer. Hepatocellular carcinoma: Impact of academic setting and hospital volume on patient survival. Dr. Jeffrey Weinreb Uhlig J, Sellers CM, Khan SA, Cha C, Kim HS. will discuss imaging Surg Oncol. 2019 Oct 12;31:111-118. options for #prostatecancer on Read More >> Yale Cancer Answers today at 7:30pm on An Update to Changing Patterns of Anal Carcinoma in the United @wnpr. Tune in to States. learn the latest information or Mahal AR, Johung KL, Mahal BA, Nguyen PL, Yu JB. subscribe to our Am J Clin Oncol. 2019 Oct 22. podcast on @iTunes Read More >> Promising new A novel regulator of ER Ca2+ drives Hippo-mediated tumorigenesis. research for patients Ma X, Lu JY, Moraru A, Teleman AA, Fang J, Qiu Y, Liu P, Xu T. with advanced #headandneckcancer. Oncogene. 2019 Oct 24. A new study by Read More >> .@BarbaraBurtness in @TheLancet shows the #immunotherapy Trusting the GPS: Going Home. drug Keytruda McCorkle R. increases survival time for patients. Cancer Nurs. 2019 Nov/Dec;42(6):515-516.

Read More >> .@YaleCancer Molecular biology and evolution of cancer: from discovery to action. hosted a #LungCancer summit @GreenHosp with @MountSinaiNYC to discuss screening Somarelli JA, Gardner H, Cannataro VL, Gunady EF, Boddy AM, Johnson and new treatments NA, Fisk JN, Gaffney SG, Chuang JH, Li S, Ciccarelli FD, Panchenko AR, including Megquier K, Kumar S, Dornburg A, DeGregori J, Townsend JP. #immunotherapy. Mol Biol Evol. 2019 Oct 23. Read More >> Thank you .@McNeill_Dr for Patterns of pain medication use associated with reported pain presenting interference in older adults with and without cancer. @YaleCancer Grand Rounds today on Davidoff AJ, Canavan ME, Feder S, Wang S, Sheinfeld E, Kent EE, Kapo creating community J, Presley CJ. partnerships and Support Care Cancer. 2019 Oct 21. engagement to decrease disparities in Read More >> cancer treatment and outcomes. A new approach to predicting risk for N2 disease in non-small cell lung cancer. Decker RH, Blasberg JD. Tune in to Yale J Thorac Dis. 2019 Sep;11(Suppl 15):S1973-S1975. Cancer Answers tonight with Dr. Natalia Read More >> Neparidze, who will highlight new advances Lymph Node Status: In Reply to Carr. in the treatment of Heller DR, Jean RA, Khan SA. multiple myeloma. The program airs at 7:30pm J Am Coll Surg. 2019 Nov;229(5):516-517. on @wnpr Connecticut Read More >> Public Radio. New research led Appendiceal Carcinoid Tumors: In Reply to Sugarbaker. by Dr. Lajos Pusztai Heller DR, Jean RA, Khan SA. .@SciReports shows a new therapeutic target J Am Coll Surg. 2019 Nov;229(5):519. to help treat patients Read More >> with triple negative #breastcancer#TNBC. Funding Opportunities Calendar

Yale Stem Cell Center Bill & Melinda Gates Foundation Grand Challenges Exploration 11th Annual Retreat (Round 24) (Day 2) The GCE initiative funds innovative ideas November 8; 8:30 AM that could lead to new vaccines, diagnostics, drugs, and other West Campus technologies targeting diseases that Conference Center claim millions of lives every year, as well as improvements an Magdalena Götz, PHD, Professor and Director d innovations in agriculture development and other priority areas of the Stem Cell of the Bill & Melinda Gates Foundation. Institute at Ludwig- Application Deadline: November 13, 2019 Maximilians- Universitat, Munich, Learn More >> Germany | Todd R. Golub, MD, Chief Scientific Officer and Melanoma Research Alliance Team Science Award Director of the Cancer Program at the Broad The MRA is pleased to announce a Special Opportunity for a Team Institute of MIT and Science Award (TSA) focused on In-transit Melanoma Research. Harvard Marcus This is an additional Special Opportunity above and beyond those Bosenberg, MD, PhD | already highlighted in first and second release of MRA's 2019/20 Grace Chen, PhD | Rong Fan, PhD | RFP. Valentina Greco, PhD | Application Deadline: November 13, 2019 Marc Hammarlund, PhD | Lilian Kabeche, Learn More >> PhD | Haifan Lin, PhD | In-Hyun Park, PhD | Valerie Reinke, PhD | Melanoma Research Alliance Awards 2019 Lauren Sansing, MD, MS, FAHA, FANA | *Pilot Award Nenad Sestan, MD, *Young Investigator Award PhD | Kaelyn Sumigray, PhD | Josien *Astro-MRA Young Investigator Award in Radiation Oncology van Wolfswinkel, PhD, *Dermatology Foundation and MRA Melanoma MSc Detection/Preventative Mid-Career Award Learn More >> These RFP's are soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the Yale Cancer Answers world. It calls for ideas that have the potential to lead to near-term November 10; 7:30 clinical application in melanoma prevention, detection, diagnosis, PM staging, and treatment. WNPR Application Deadline: November 18, 2019 Men's Health Daniel S. Kellner, MD Learn More >> Learn More >>

The Chan Zuckerberg Initiative Single-Cell Analysis of MB&B Special Inflammation Seminar The Chan Zuckerberg Initiative invites applications for two-year November 11; 10:00 collaborative pilot projects focused on the role of inflammation in AM maintaining health and triggering disease. Bass Center, 305 Application Deadline: November 19, 2019 Cryo-EM Reveals Active Site Learn More >> Coordination Within a Multienzyme Pre- rRNAprocessing The Doris Duke Clinical Scientist Development Award Complex This award provides grants to junior physician scientists to facilitate Monica Pillon their transition to independent clinical research careers. Learn More >> Application Deadline: November 19, 2019 Genetics Clinical Learn More >> Grand Rounds November 12; 10:15 Mobile Health: Technology and Outcomes in Low and Middle AM Income Countries (R21/R33) Sterling Hall of Medicine, I-304 The purpose of this FOA is to encourage exploratory/developmental Integrated Genomic research applications that propose to study the development, Analysis for Cancer validation, feasibility, and effectiveness of innovative mobile health Predisposition and (mHealth) interventions or tools specifically suited for low- and middle-income countries that utilize new or emerging technology, Bone Marrow Failure platforms, systems, or analytics. Syndrome Application Deadline: November 19, 2019 Marilyn M. Li, MD Learn More >> Learn More >>

Genetics Department U.S.-Israel Binational Foundation BSF Research Grants Seminar Series The U.S.-Israel Binational Science Foundation (BSF) promotes November 12; 11:30 scientific relations between the U.S. and Israel by supporting AM collaborative research projects in a wide range of basic and applied The Anlyan Center scientific fields, for peaceful and non-profit purposes. Auditorium, N-107 Hyperactive RAS Application Deadline: November 20, 2019 Signaling in Learn More >> Developmental Disorders and Blood Cancer 2019 Class of '61 Cancer Research Award Kevin Shannon, PhD This annual Award recognizes significant accomplishment in cancer Learn More >> research at Yale University by a young member of the faculty, coupled with the expectation for future outstanding contributions to Yale Cancer Center our understanding of the causes of cancer and to the development Grand Rounds of novel cancer treatments. November 12; 12:00 Application Deadline: November 22, 2019 PM Learn More >> 55 Park Street, Park Street Auditorium

Genomic Profiling, Big 2020 NCCN Young Investigator Award Data, and Machine Through the YIA Program, the NCCN Foundation invites proposals Learning Drive Precision Cancer Care from early career investigators with innovative ideas and an interest in improving the quality, effectiveness, efficiency and accessibility of Marilyn M. Li, MD care provided to cancer patients. Learn More >>

Deadline for Application: December 2, 2019 Yale Cooperative Learn More >> Canter of Excellence in Hematology (YCCEH) Seminar Damon Runyon Cancer Research Foundation Physician- November 12; 12:00 Scientist Training Award PM The Damon Runyon Physician-Scientist Training Award is designed Brady Auditorium, to encourage more physicians to pursue research careers. B131 A Long and Twisting Application Deadline: December 2, 2019 Road to Understanding Learn More >> RUNX1 Haploinsufficient FPD/AML Breast Cancer Alliance Breast Surgery Fellowship Grant Mortimer Poncz, MD The mission of the BCA is to improve survival rates and quality of Learn More >> life for those impacted by breast cancer through better prevention, early detection, treatment and cure. To promote these goals, we invest in innovative research, breast surgery fellowships, regional Cancer Microbiology education, dignified support and screening for the underserved. Research Program Application Deadline: December 10, 2019 Seminar November 12; 1:00 Learn More >> PM Hope Memorial Building, H-110 Cancer Intervention and Surveillance Modeling Network (CISNET) (U01) Dissecting the HPV Entry Pathway with This FOA invites multiple PD/PI applications for collaborative Artificial research projects using simulation and other modeling techniques Transmembrane for specific cancer types. Proteins Jian Xie, PhD Application Deadline: December 10, 2019 Learn More >> Learn More >> Free Prostate Cancer Alex's Lemonade Stand (Childhood Cancer) Young Investigator Screening Award November 12; 3:30 PM This grant is designed to support scientists during their fellowship Bridgeport Hospital, training or early in their research careers. Demonstration of MedEase Unit outstanding mentorship and demonstration of a career plan that Learn More >> shows commitment to pediatric cancer investigation are critical components of a successful application. Cancer Biology Application Deadline: December 16, 2019 Meeting Learn More >> November 13; 4:00 PM

Brady Memorial Alex's Lemonade Stand (Childhood Cancer) Epidemiology Library, BML-137 Grant Politi Lab Presents: Epidemiology awards "Overcoming Acquired Resistance to First-line will support investigators pursuing research studies in human p Osimertinib in EGFR opulations using epidemiological Mutant Lung approaches, in order to significantly contribute to the understan Adenocarcinoma: Gen ding of childhood cancers. etic and Epigenetic Mechanisms Application Deadline: December 16, 2019 Jacqueline Starrett and Learn More >> Fernando de Miguel Learn More >> Informatics Technology for Cancer Research Education Center (UE5) Breathe Easier with Lung Screening The overarching goal of this NCI UE5 program is to support November 13; 5:30 educational activities that complement and/or enhance the training PM of a workforce to meet the nation's biomedical, behavioral and Lawrence + Memorial clinical research needs. Hospital, Baker Application Deadline: December 19, 2019 Auditorium Louis Mazzarelli, MD Learn More >> Learn More >>

Yale Cancer Center K12 Calabresi Immuno-Oncology Training 2019 ACS CAN Program Scholar Awards Connecticut Policy We are pleased to solicit applications for the Yale Cancer Center Forum (YCC) K12 Calabresi Immuno-Oncology Training Program (IOTP) November 14; 8:00 AM Scholar Award for junior faculty to enhance research skills beyond the training provided during graduate and postgraduate training. Pond House Café, Elizabeth Park, West Application Deadline: January 3, 2020 Hartford Application Instructions >> The Future of Cancer Care: The Role of Learn More >> Biomarkers in

Pathology Grand Rounds November 14; 12:30 PM Fitkin Memorial Pavilion Auditorium, LMP 1094 Decoding Lynch Syndrome and MSI: The Pathologist's Role - Constantly Evolving and Consistently Essential Jinru Shia, MD Learn More >>

Cancer Genetics and Prevention Seminar November 14; 2:30 PM Orchard Medical Center, 107-109 Learn More >>

Free Prostate Cancer Screening Event November 14; 5:00 PM Yale Physicians Building, 3rd Fl. Movember Men's Health Fair Learn More >>

Free Prostate Cancer Screening Event November 14; 5:00 PM Lawrence + Memorial Hospital, 2-013 Movember Men's Health Fair Learn More >>

Yale Cancer Answers November 17; 7:30 PM WNPR Healthy Eating and the Holidays Courtney McGowan & Heidi Larson Learn More >>

MB&B Special Seminar November 18; 10:00 AM Bass Center, 305 Better Together: Long- Distance Interactions Between RNA Polymerases via DNA Supercoiling Sangjin Kim, PhD Learn More >>

The Yale Institute for Biospheric Studies Presents November 18; 4:00 PM Peabody Museum Novel Approaches to Combating Therapeutic Resistance Hesper Rego, PhD | Jessica Cunningham | Elsa Hanses | Joshua Weitz Learn More >>

Genetics Clinical Grand Rounds November 19, 10:15 AM Sterling Hall of Medicine, SHM I-304 Preti Jain, PhD Learn More >>

Yale Cancer Center Grand Rounds - Calabresi Memorial Lecture November 19; 12:00 PM 55 Park Street, Park Street Auditorium Cancer Control in the 21st Century Otis Brawley, MD Learn More >>

Yale Cancer Center Seminar November 20; 12:00 PM Fitkin Memorial Pavilion Auditorium, LMP 1094 Targeting the Tumor Microenvironment in Breast Cancer Yara Abdou, MD Learn More >>

Smilow Screening and Prevention Informational Table November 21; 11:00 AM Yale New Haven Hospital St. Raphael Campus National Lung Cancer Awareness Month Event Learn More >>

Pathology Grand Rounds November 21; 12:30 PM Fitkin Memorial Pavilion Auditorium, LMP 1094 New Soft Tissue Fusion Tumors - Diagnostic and Therapeutic Significance Markku Miettinen, MD Learn More >>

Cancer Genetics and Prevention Seminar November 21; 2:30 PM Orchard Medical Center, 107-109 Learn More >>

Lung Cancer Screening Panel Discussion November 21; 6:00 PM Westerly Hospital, Nardone Conference Center Louis Mazzarelli, MD Learn More >>

Submissions Please submit your recent publication and grant announcements to:

Renee Gaudette Director, Public Affairs and Communications